<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27965390</article-id>
<article-id pub-id-type="pmc">5206576</article-id>
<article-id pub-id-type="publisher-id">201618737</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1618737114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>DNA methylation in the gene body influences MeCP2-mediated gene repression</article-title>
<alt-title alt-title-type="short">MeCP2 and gene-body DNA methylation repress genes</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kinde</surname>
<given-names>Benyam</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Dennis Y.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greenberg</surname>
<given-names>Michael E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gabel</surname>
<given-names>Harrison W.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Neurobiology, <institution>Harvard Medical School</institution>, Boston, <addr-line>MA</addr-line> 02115;</aff>
<aff id="aff2"><sup>b</sup>Department of Neuroscience, <institution>Washington University School of Medicine</institution>, St. Louis, <addr-line>MO</addr-line> 63110</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence may be addressed. Email: <email>gabelh@wustl.edu</email> or <email>michael_greenberg@hms.harvard.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Contributed by Michael E. Greenberg, November 21, 2016 (sent for review June 22, 2016; reviewed by Anne Brunet and Li-Huei Tsai)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: B.K., M.E.G., and H.W.G. designed research; B.K., D.Y.W., and H.W.G. performed research; B.K., D.Y.W., and H.W.G. analyzed data; and B.K., M.E.G., and H.W.G. wrote the paper.</p>
</fn>
<fn fn-type="con">
<p>Reviewers: A.B., Stanford University; and L.-H.T., Massachusetts Institute of Technology.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>27</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>113</volume>
<issue>52</issue>
<fpage>15114</fpage>
<lpage>15119</lpage>
<permissions></permissions>
<self-uri xlink:href="pnas.201618737.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Mutations in the methyl-CpG binding protein 2 (<italic>MECP2</italic>) lead to the severe neurological disorder Rett syndrome, but our understanding of how MeCP2 regulates gene expression in the brain has been limited. Recently we uncovered evidence that MeCP2 controls transcription of very long genes with critical neuronal functions by binding a unique form of DNA methylation, enriched in neurons. Here, we provide evidence that MeCP2 represses transcription by binding within transcribed regions of genes. We show that this repressive effect is proportional to the total number of methylated DNA binding sites for MeCP2 within each gene. Our findings suggest a model in which MeCP2 represses transcription of long neuronal genes that contain many methylated binding sites by impeding transcriptional elongation.</p>
</abstract>
<abstract>
<p>Rett syndrome is a severe neurodevelopmental disorder caused by mutations in the methyl-CpG binding protein gene (<italic>MECP2</italic>). MeCP2 is a methyl-cytosine binding protein that is proposed to function as a transcriptional repressor. However, multiple gene expression studies comparing wild-type and MeCP2-deficient neurons have failed to identify gene expression changes consistent with loss of a classical transcriptional repressor. Recent work suggests that one function of MeCP2 in neurons is to temper the expression of the longest genes in the genome by binding to methylated CA dinucleotides (mCA) within transcribed regions of these genes. Here we explore the mechanism of mCA and MeCP2 in fine tuning the expression of long genes. We find that mCA is not only highly enriched within the body of genes normally repressed by MeCP2, but also enriched within extended megabase-scale regions surrounding MeCP2-repressed genes. Whereas enrichment of mCA exists in a broad region around these genes, mCA together with mCG within gene bodies appears to be the primary driver of gene repression by MeCP2. Disruption of methylation at CA sites within the brain results in depletion of MeCP2 across genes that normally contain a high density of gene-body mCA. We further find that the degree of gene repression by MeCP2 is proportional to the total number of methylated cytosine MeCP2 binding sites across the body of a gene. These findings suggest a model in which MeCP2 tunes gene expression in neurons by binding within the transcribed regions of genes to impede the elongation of RNA polymerase.</p>
</abstract>
<kwd-group>
<kwd>DNA methylation</kwd>
<kwd>Rett syndrome</kwd>
<kwd>MeCP2</kwd>
<kwd>transcription</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">Rett syndrome research trust</funding-source>
<award-id rid="sp1">NA</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp2">5R01NS048276-12</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp3">T32GM007753</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">Howard Hughes Medical Institute (HHMI)<named-content content-type="funder-id">100000011</named-content></funding-source>
<award-id rid="sp4">NA</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>